Our XAI models further revealed that by boosting the B cell and CD8+ T cell fractions or B cell and NK T cell fractions in the TME to levels above their inflection points—identified by XAI analysis in this study—the survival rate of breast cancer patients could increase by up to 18%. This evidence concerns the gene CD8A and breast cancer.